Kong FYS - Search Results

1

Development of New Antimicrobials for Urogenital Gonorrhea Therapy: Clinical Trial Design Considerations.

Hook EW, Newman L, Drusano G, Evans S, Handsfield HH, Jerse AE, Kong FYS, Lee JY, Taylor SN, Deal C. Hook EW, et al. Among authors: kong fys. Clin Infect Dis. 2020 Mar 17;70(7):1495-1500. doi: 10.1093/cid/ciz899. Clin Infect Dis. 2020. PMID: 31538646 Free PMC article.

2

Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials.

Kong FY, Tabrizi SN, Law M, Vodstrcil LA, Chen M, Fairley CK, Guy R, Bradshaw C, Hocking JS. Kong FY, et al. Clin Infect Dis. 2014 Jul 15;59(2):193-205. doi: 10.1093/cid/ciu220. Epub 2014 Apr 11. Clin Infect Dis. 2014. PMID: 24729507

3

Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract.

Craig AP, Kong FY, Yeruva L, Hocking JS, Rank RG, Wilson DP, Donovan B. Craig AP, et al. BMC Infect Dis. 2015 Apr 30;15:200. doi: 10.1186/s12879-015-0939-3. BMC Infect Dis. 2015. PMID: 25925662 Free PMC article.

4

The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis.

Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FY, Hocking JS. Lau A, et al. Clin Infect Dis. 2015 Nov 1;61(9):1389-99. doi: 10.1093/cid/civ644. Epub 2015 Aug 3. Clin Infect Dis. 2015. PMID: 26240201 Review.

5

Reply to Deguchi et al.

Kong FY, Bradshaw CS, Lau A, Fairley CK, Hocking JS. Kong FY, et al. Clin Infect Dis. 2016 Feb 1;62(3):406-7. doi: 10.1093/cid/civ899. Epub 2015 Oct 22. Clin Infect Dis. 2016. PMID: 26494824 No abstract available.

6

Is there a future for the ongoing use of azithromycin for the treatment of Neisseria gonorrhoeae?

Kong FYS, Hocking JS, Fairley CK. Kong FYS, et al. Clin Microbiol Infect. 2020 Feb;26(2):137-139. doi: 10.1016/j.cmi.2019.10.015. Epub 2019 Oct 22. Clin Microbiol Infect. 2020. PMID: 31654792 Free article. No abstract available.

7

Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.

Kong FYS, Hatzis CL, Lau A, Williamson DA, Chow EPF, Fairley CK, Hocking JS. Kong FYS, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3109-3119. doi: 10.1093/jac/dkaa300. J Antimicrob Chemother. 2020. PMID: 32747940

8

Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trial.

Kong FYS, Unemo M, Lim SH, Latch N, Williamson DA, Roberts JA, Wallis SC, Parker SL, Landersdorfer CB, Yap T, Fairley CK, Chow EPF, Lewis DA, Hammoud MA, Hocking JS. Kong FYS, et al. BMJ Open. 2022 Nov 11;12(11):e064782. doi: 10.1136/bmjopen-2022-064782. BMJ Open. 2022. PMID: 36368750 Free PMC article. Clinical Trial.

9

STI pathogens in the oropharynx: update on screening and treatment.

Chow EPF, Fairley CK, Kong FYS. Chow EPF, et al. Among authors: kong fys. Curr Opin Infect Dis. 2024 Feb 1;37(1):35-45. doi: 10.1097/QCO.0000000000000997. Epub 2023 Dec 7. Curr Opin Infect Dis. 2024. PMID: 38112085 Review.

10

Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model.

Jacobsson S, Golparian D, Oxelbark J, Kong FYS, Da Costa RMA, Franceschi F, Brown D, Louie A, Drusano G, Unemo M. Jacobsson S, et al. Among authors: kong fys. Front Pharmacol. 2023 Dec 7;14:1291885. doi: 10.3389/fphar.2023.1291885. eCollection 2023. Front Pharmacol. 2023. PMID: 38130409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page